Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

OBJECTIVE: As of 3 September 2013, 399 cases of natalizumab-associated progressive multifocal leukoencephalopathy (PML) were confirmed in multiple sclerosis (MS) patients. We evaluated outcomes of natalizumab-treated MS patients who were asymptomatic at PML diagnosis. METHODS: Analyses included data...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong-Si, Tuan, Richman, Sandra, Wattjes, Mike P, Wenten, Made, Gheuens, Sarah, Philip, Jeffrey, Datta, Shoibal, McIninch, James, Bozic, Carmen, Bloomgren, Gary, Richert, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241803/
https://www.ncbi.nlm.nih.gov/pubmed/25493267
http://dx.doi.org/10.1002/acn3.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241803/
https://www.ncbi.nlm.nih.gov/pubmed/25493267
http://dx.doi.org/10.1002/acn3.114

Ejemplares similares